New User? Click here to register

FDG Pet CTscan for treatment response evaluation.

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Willy VANGU<br /> MD, MMed, MSc, PhD, Nuclear Medicine, Johannesburg, South Africa

Willy VANGU
MD, MMed, MSc, PhD, Nuclear Medicine, Johannesburg, South Africa

Hormone Receptor-Positive Breast Cancer: Emerging Treatments
Georgia DEMETRIOU
Overview of high-risk patient screening.
Dana HADDAD
Can you present the challenges of the AROME session?
Yazid BELKACEMI
Oncologist-Radiotherapist, Créteil, France
Radiotherapy: Indications and limitations.
Yazid BELKACEMI
New advance in Oncology in UAE
Humaid AL SHAMSI